{"id":56861,"date":"2026-06-04T21:12:21","date_gmt":"2026-06-04T12:12:21","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4577\/"},"modified":"2026-08-23T13:31:59","modified_gmt":"2026-08-23T04:31:59","slug":"company-4577","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4577\/","title":{"rendered":"DAITO PHARMACEUTICAL CO.LTD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4577","DATE":"2026-01-09","longName":"Daito Pharmaceutical Co.,Ltd.","company_name_ja":"","fullTimeEmployees":1073,"address":"","phone":"","website":"https:\/\/www.daitonet.co.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":1363,"financialCurrency":"","marketCap":40189,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":107.48999999999999,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":1500,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-07-01T05:37:30.178435\", \"ticker\": \"4577\", \"ticker_full\": \"4577.T\", \"company_name\": \"DAITO PHARMACEUTICAL CO.LTD\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"0\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 1, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 1, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 1220.0, \"high\": 1500.0, \"low\": 1500.0, \"mean\": 1500.0, \"median\": 1500.0}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 16.14, \"institution_pct\": 30.91, \"major_holders\": [{\"label\": \"\", \"value\": 16.14}, {\"label\": \"\", \"value\": 30.91}, {\"label\": \"\", \"value\": 36.86}, {\"label\": \"\", \"value\": 43.0}], \"institutional_holders\": [{\"holder\": \"MFS Series Trust V-MFS International New Discovery Fund\", \"shares\": 1040945, \"date_reported\": \"2026-03-31\", \"pct_held\": 3.61, \"pct_change\": -23.58, \"value\": 1269952900}, {\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 373382, \"date_reported\": \"2026-01-31\", \"pct_held\": 1.29, \"pct_change\": 0.0, \"value\": 455526040}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.\", \"shares\": 248164, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.86, \"pct_change\": 0.0, \"value\": 302760080}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 217800, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.75, \"pct_change\": 0.0, \"value\": 265716000}, {\"holder\": \"American Century ETF Trust-Avantis International Small Cap Value ETF\", \"shares\": 165100, \"date_reported\": \"2026-05-31\", \"pct_held\": 0.57, \"pct_change\": 25.46, \"value\": 201422000}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 154818, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.54, \"pct_change\": 4.74, \"value\": 188877960}, {\"holder\": \"Dimensional ETF Trust-Dimensional International Small Cap Value ETF\", \"shares\": 137552, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.48, \"pct_change\": 3.3, \"value\": 167813440}, {\"holder\": \"Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund\", \"shares\": 88620, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.31, \"pct_change\": 0.0, \"value\": 108116400}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap \", \"shares\": 89260, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.31, \"pct_change\": -11.24, \"value\": 108897200}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.\", \"shares\": 84468, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.29, \"pct_change\": -2.54, \"value\": 103050960}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":20,"get_dividend_history_year2":37.5,"get_dividend_history_year3":32.5,"get_dividend_history_year4":28.640000000000001,"get_dividend_history_year5":29.550000000000001,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:33:45.884501\", \"ticker\": \"4577\", \"ticker_full\": \"4577.T\", \"company_name\": \"DAITO PHARMACEUTICAL CO.LTD\", \"company_info\": {\"name_en\": \"DAITO PHARMACEUTICAL CO.LTD\", \"long_name\": \"Daito Pharmaceutical Co.,Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.daitonet.co.jp\", \"employees\": null, \"country\": \"Japan\", \"city\": \"Toyama\", \"address\": \"326 Yokamachi\", \"description\": \"Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 1341.0, \"deviation\": 1.64, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 1287.96, \"deviation\": 5.83, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 1238.91, \"deviation\": 10.02, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 1296.47, \"deviation\": 5.13, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 107.49, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}, {\"year\": 2025, \"revenue\": 50643000000.0, \"revenue_fmt\": \"\u00a5506\u5104\", \"gross_profit\": 8637000000.0, \"gross_profit_fmt\": \"\u00a586\u5104\", \"operating_income\": 2620000000.0, \"operating_income_fmt\": \"\u00a526\u5104\", \"ebit\": 3081000000.0, \"ebit_fmt\": \"\u00a531\u5104\", \"net_income\": 1908000000.0, \"net_income_fmt\": \"\u00a519\u5104\", \"eps\": 63.63, \"operating_margin\": 5.17, \"total_assets\": 78004000000.0, \"total_assets_fmt\": \"\u00a5780\u5104\", \"total_equity\": 52003000000.0, \"total_equity_fmt\": \"\u00a5520\u5104\", \"total_debt\": 11885000000.0, \"total_debt_fmt\": \"\u00a5119\u5104\", \"total_cash\": 2207000000.0, \"total_cash_fmt\": \"\u00a522\u5104\", \"equity_ratio\": 66.67, \"de_ratio\": 0.23, \"current_ratio\": 2.45, \"operating_cf\": 5897000000.0, \"operating_cf_fmt\": \"\u00a559\u5104\", \"investing_cf\": -7365000000.0, \"investing_cf_fmt\": \"-\u00a574\u5104\", \"financing_cf\": 1002000000.0, \"financing_cf_fmt\": \"\u00a510\u5104\", \"free_cf\": -1133000000.0, \"free_cf_fmt\": \"-\u00a511\u5104\", \"net_margin\": 3.77, \"roe\": 3.67, \"roa\": 2.45}, {\"year\": 2024, \"revenue\": 46895000000.0, \"revenue_fmt\": \"\u00a5469\u5104\", \"gross_profit\": 9839000000.0, \"gross_profit_fmt\": \"\u00a598\u5104\", \"operating_income\": 3894000000.0, \"operating_income_fmt\": \"\u00a539\u5104\", \"ebit\": 4259000000.0, \"ebit_fmt\": \"\u00a543\u5104\", \"net_income\": 3295000000.0, \"net_income_fmt\": \"\u00a533\u5104\", \"eps\": 105.0, \"operating_margin\": 8.3, \"total_assets\": 77708000000.0, \"total_assets_fmt\": \"\u00a5777\u5104\", \"total_equity\": 52068000000.0, \"total_equity_fmt\": \"\u00a5521\u5104\", \"total_debt\": 8719000000.0, \"total_debt_fmt\": \"\u00a587\u5104\", \"total_cash\": 2727000000.0, \"total_cash_fmt\": \"\u00a527\u5104\", \"equity_ratio\": 67.0, \"de_ratio\": 0.17, \"current_ratio\": 2.24, \"operating_cf\": 5182000000.0, \"operating_cf_fmt\": \"\u00a552\u5104\", \"investing_cf\": -5930000000.0, \"investing_cf_fmt\": \"-\u00a559\u5104\", \"financing_cf\": -183000000.0, \"financing_cf_fmt\": \"-\u00a52\u5104\", \"free_cf\": -1094000000.0, \"free_cf_fmt\": \"-\u00a511\u5104\", \"net_margin\": 7.03, \"roe\": 6.33, \"roa\": 4.24}, {\"year\": 2023, \"revenue\": 45101000000.0, \"revenue_fmt\": \"\u00a5451\u5104\", \"gross_profit\": 10331000000.0, \"gross_profit_fmt\": \"\u00a5103\u5104\", \"operating_income\": 5208000000.0, \"operating_income_fmt\": \"\u00a552\u5104\", \"ebit\": 5088000000.0, \"ebit_fmt\": \"\u00a551\u5104\", \"net_income\": 3600000000.0, \"net_income_fmt\": \"\u00a536\u5104\", \"eps\": 113.71, \"operating_margin\": 11.55, \"total_assets\": 70552000000.0, \"total_assets_fmt\": \"\u00a5706\u5104\", \"total_equity\": 50672000000.0, \"total_equity_fmt\": \"\u00a5507\u5104\", \"total_debt\": 4889000000.0, \"total_debt_fmt\": \"\u00a549\u5104\", \"total_cash\": 3607000000.0, \"total_cash_fmt\": \"\u00a536\u5104\", \"equity_ratio\": 71.82, \"de_ratio\": 0.1, \"current_ratio\": 2.64, \"operating_cf\": 4155000000.0, \"operating_cf_fmt\": \"\u00a542\u5104\", \"investing_cf\": -5566000000.0, \"investing_cf_fmt\": \"-\u00a556\u5104\", \"financing_cf\": 616000000.0, \"financing_cf_fmt\": \"\u00a56\u5104\", \"free_cf\": -1401000000.0, \"free_cf_fmt\": \"-\u00a514\u5104\", \"net_margin\": 7.98, \"roe\": 7.1, \"roa\": 5.1}, {\"year\": 2022, \"revenue\": 43464000000.0, \"revenue_fmt\": \"\u00a5435\u5104\", \"gross_profit\": 11458000000.0, \"gross_profit_fmt\": \"\u00a5115\u5104\", \"operating_income\": 6553000000.0, \"operating_income_fmt\": \"\u00a566\u5104\", \"ebit\": 6729000000.0, \"ebit_fmt\": \"\u00a567\u5104\", \"net_income\": 4668000000.0, \"net_income_fmt\": \"\u00a547\u5104\", \"eps\": 0, \"operating_margin\": 15.08, \"total_assets\": 64939000000.0, \"total_assets_fmt\": \"\u00a5649\u5104\", \"total_equity\": 47304000000.0, \"total_equity_fmt\": \"\u00a5473\u5104\", \"total_debt\": 3447000000.0, \"total_debt_fmt\": \"\u00a534\u5104\", \"total_cash\": 4381000000.0, \"total_cash_fmt\": \"\u00a544\u5104\", \"equity_ratio\": 72.84, \"de_ratio\": 0.07, \"current_ratio\": 2.69, \"operating_cf\": 4370000000.0, \"operating_cf_fmt\": \"\u00a544\u5104\", \"investing_cf\": -4400000000.0, \"investing_cf_fmt\": \"-\u00a544\u5104\", \"financing_cf\": 989000000.0, \"financing_cf_fmt\": \"\u00a510\u5104\", \"free_cf\": -363000000.0, \"free_cf_fmt\": \"-\u00a54\u5104\", \"net_margin\": 10.74, \"roe\": 9.87, \"roa\": 7.19}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 29.55}, {\"year\": 2023, \"amount\": 28.64}, {\"year\": 2024, \"amount\": 32.5}, {\"year\": 2025, \"amount\": 37.5}, {\"year\": 2026, \"amount\": 20.0}], \"latest\": 20.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-56861","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>DAITO PHARMACEUTICAL CO.LTD - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4577\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4577\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4577\/\",\"name\":\"DAITO PHARMACEUTICAL CO.LTD - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T12:12:21+00:00\",\"dateModified\":\"2026-08-23T04:31:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4577\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4577\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4577\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DAITO PHARMACEUTICAL CO.LTD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DAITO PHARMACEUTICAL CO.LTD - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4577\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4577\/","url":"https:\/\/japanir.jp\/en\/company\/company-4577\/","name":"DAITO PHARMACEUTICAL CO.LTD - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T12:12:21+00:00","dateModified":"2026-08-23T04:31:59+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4577\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4577\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4577\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"DAITO PHARMACEUTICAL CO.LTD"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/56861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=56861"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=56861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}